Skip to main content
· 11/30/2006

Federal Case

Citations

  • 470 F.3d 785
  • 2006 U.S. App. LEXIS 29394

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • labeling requirements are “manifestation of a congressional plan to create a ‘closed system’ designed to guarantee safe and effective drugs for consumers in the United States”
  • labeling requirements are “manifestation of a congressional plan to create a ‘closed system’ designed to guarantee safe and effective drugs 12 No. 05-4608 for consumers in the United States”
  • noting in an antitrust case that the importation of drugs from Canada violates federal law 11 drugs are “unapproved” — without demonstrating how that violates § 355(a) — is therefore not enough on its own to state the offense of conspiracy to violate § 355(a
  • “The absence of competition from Canadian sources in the domestic prescription drug market, therefore, is caused by the federal statutory and regulatory scheme adopted by the United States government, not by the conduct of the defendants.”

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.